Cargando…

Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice

The ectodomain of matrix protein 2 (M2e) is highly conserved among influenza A viruses and can be a promising candidate antigen for a broadly cross-protective vaccine. In this study, a tetrameric M2e (tM2e) and a truncated form of flagellin (tFliC) were coincorporated into virus-like particles (VLPs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li, Wang, Ying-Chun, Feng, Hao, Ahmed, Tamanna, Compans, Richard W., Wang, Bao-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745920/ https://www.ncbi.nlm.nih.gov/pubmed/23984396 http://dx.doi.org/10.1155/2013/686549

Ejemplares similares

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
por: Wang, Bao-Zhong, et al.
Publicado: (2010)

Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice
por: Luo, Yuan, et al.
Publicado: (2018)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice
por: Shi, Lili, et al.
Publicado: (2023)

Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
por: Song, Jae-Min, et al.
Publicado: (2011)

An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus
por: Leung, Ho-Chuen, et al.
Publicado: (2015)

Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity
por: McMaster, Sean R., et al.
Publicado: (2015)

Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2022)

Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses
por: Mohan, Teena, et al.
Publicado: (2017)

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza
por: Wang, Jiong, et al.
Publicado: (2015)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats
por: Straight, Timothy M, et al.
Publicado: (2008)

Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine
por: Holzer, Barbara, et al.
Publicado: (2018)

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)

Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
por: Lambe, Teresa, et al.
Publicado: (2013)

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Tetrameric Neuraminidase of Influenza A Virus Is Required to Induce Protective Antibody Responses in Mice
por: Deng, Xiren, et al.
Publicado: (2021)

Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
por: Mardanova, Eugenia S., et al.
Publicado: (2015)

Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant
por: Vassilieva, Elena V., et al.
Publicado: (2011)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
por: Zhao, Min, et al.
Publicado: (2018)

Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza
por: Gooch, Karen E., et al.
Publicado: (2019)

An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses
por: Xiong, Feifei, et al.
Publicado: (2023)

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
por: Marriott, Anthony C., et al.
Publicado: (2021)

MUC1 ectodomain is a flagellin-targeting decoy receptor and biomarker operative during Pseudomonas aeruginosa lung infection
por: Verceles, Avelino C., et al.
Publicado: (2021)

Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles
por: Braz Gomes, Keegan, et al.
Publicado: (2023)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice
por: Quan, Fu-Shi, et al.
Publicado: (2010)

Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti–Influenza A Antibodies
por: Sui, Jianhua, et al.
Publicado: (2011)

Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022)

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
por: Oltean, Teodora, et al.
Publicado: (2022)

Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
por: Laddy, Dominick J., et al.
Publicado: (2008)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
por: Bliss, Carly M., et al.
Publicado: (2022)

Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice
por: Liu, Qiliang, et al.
Publicado: (2014)

Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein
por: Andersson, Anne-Marie Carola, et al.
Publicado: (2012)

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza
por: Lynch, Garry W, et al.
Publicado: (2009)

Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards
por: Segovia, Karen M., et al.
Publicado: (2017)

Influenza infection fortifies local lymph nodes to promote lung-resident heterosubtypic immunity
por: Paik, Daniel H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ki44ao3rt8p5l9hjk0ivsgmb7j